
Boston-based Adaptilens, a developer of an adjustable intraocular lens, has secured $1.6 million in seed funding. Pillar VC led the round with participation from Accanto Partners.
Source: Press Release
Boston-based Adaptilens, a developer of an adjustable intraocular lens, has secured $1.6 million in seed funding.
Boston-based Adaptilens, a developer of an adjustable intraocular lens, has secured $1.6 million in seed funding. Pillar VC led the round with participation from Accanto Partners.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination